Home Tags Moderna
More than half of today’s unicorn health startups haven’t published any influential research — and some experts say that raises the ...
In a new study, an early Theranos whistle-blower and Stanford professor of medicine analyzes a cluster of $1 billion healthcare startups and finds very few are publishing high-impact papers.
Moderna Therapeutics started trading Friday in its initial public offering under the ticker "MRNA." The biotech raised more than $600 million.
The biotech Moderna is developing medical treatments based on messenger RNA, though it doesn't have any on the market yet.
BI PRIME: In 2018, healthcare startups have raised $15 billion in funding, the most raised in the first half of the year in the last decade. By July, a new crop of unicorns — startups with valuations over $1 billion — were born, while others increased their already billion-dollar valuations.
BI PRIME: From companies harnessing the plant microbiome to buzzy biotechs working on cutting-edge technology, here are the unicorns to keep an eye on in 2018.